The North America Hearing Loss Disease Treatment Market would witness market growth of 4.2% CAGR during the forecast period (2022-2028).
Hearing loss is avoidable with some appropriate plans. Because of development in technologies, various methods are present to detect hearing loss at an early phase of development Medicines & surgeries are usually suggested for various kinds of hearing problems. Antibiotic tablets or drops are a typical treatment choice for some ear infections. In some circumstances, steroids are also utilized for treating sudden hearing loss or inflammation.
The doctors might advise hearing aids or different assistive listening devices if the condition do not get better with medicines. Hearing devices help in amplifying sound in the ear and thus enhance overall hearing. The hearing devices come in several shapes, styles, and sizes. These devices influence the hearing loss disease treatment market. Hearing devices are divided into cochlear implants and hearing aids.
In the United States, approximately 30 million adults have a certain level of hearing loss. Hearing loss may have an adverse consequence on relationships, communication, emotional well-being, & school or work performance. The FDA on 17th August 2022 launched “Establishing Over-the-Counter Hearing Aids” which was aimed to enhance access to effective, safe, and affordable hearing aids for countless American people and is currently in effect. This measure allows consumers 18 years old and above with distinguished mild or moderate hearing loss to buy hearing aids directly from online retailers or stores without requirement of a prescription, a fitting adjustment, or a medical test by an audiologist. This will lead to an increase in the growth of hearing disease loss treatment.
The US market dominated the North America Hearing Loss Disease Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,600.3 Million by 2028.The Canada market is poised to grow at a CAGR of 6.2% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 5.9% during (2022 - 2028).
Based on Disease Type, the market is segmented into Sensorineural, Conductive and Mixed. Based on Product, the market is segmented into Devices and Drugs. Based on End-user, the market is segmented into Otology Clinics, Hospitals and Ambulatory Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Hearing Loss Disease Treatment Market is Estimated to reach $16 Billion by 2028, at a CAGR of 4.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Astellas Pharma, Inc, WS Audiology A/S, Otonomy, Inc, Sensorion, Frequency Therapeutics, Inc, Acousia Therapeutics GmbH, Pipeline Therapeutics, Inc, Audina Hearing Instruments, Inc, and Audifon GmbH & CO. KG.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Sensorineural
- Conductive
- Mixed
By Product
By End-user
- Otology Clinics
- Hospitals
- Ambulatory Clinics
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Novartis AG
- Astellas Pharma, Inc
- WS Audiology A/S
- Otonomy, Inc
- Sensorion
- Frequency Therapeutics, Inc
- Acousia Therapeutics GmbH
- Pipeline Therapeutics, Inc
- Audina Hearing Instruments, Inc
- Audifon GmbH & CO. KG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hearing Loss Disease Treatment Market, by Disease Type
1.4.2 North America Hearing Loss Disease Treatment Market, by Product
1.4.3 North America Hearing Loss Disease Treatment Market, by End-user
1.4.4 North America Hearing Loss Disease Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Hearing Loss Disease Treatment Market
Chapter 4. North America Hearing Loss Disease Treatment Market by Disease Type
4.1 North America Sensorineural Market by Country
4.2 North America Conductive Market by Country
4.3 North America Mixed Market by Country
Chapter 5. North America Hearing Loss Disease Treatment Market by Product
5.1 North America Devices Market by Country
5.2 North America Drugs Market by Country
Chapter 6. North America Hearing Loss Disease Treatment Market by End-user
6.1 North America Otology Clinics Market by Country
6.2 North America Hospitals Market by Country
6.3 North America Ambulatory Clinics Market by Country
Chapter 7. North America Hearing Loss Disease Treatment Market by Country
7.1 US Hearing Loss Disease Treatment Market
7.1.1 US Hearing Loss Disease Treatment Market by Disease Type
7.1.2 US Hearing Loss Disease Treatment Market by Product
7.1.3 US Hearing Loss Disease Treatment Market by End-user
7.2 Canada Hearing Loss Disease Treatment Market
7.2.1 Canada Hearing Loss Disease Treatment Market by Disease Type
7.2.2 Canada Hearing Loss Disease Treatment Market by Product
7.2.3 Canada Hearing Loss Disease Treatment Market by End-user
7.3 Mexico Hearing Loss Disease Treatment Market
7.3.1 Mexico Hearing Loss Disease Treatment Market by Disease Type
7.3.2 Mexico Hearing Loss Disease Treatment Market by Product
7.3.3 Mexico Hearing Loss Disease Treatment Market by End-user
7.4 Rest of North America Hearing Loss Disease Treatment Market
7.4.1 Rest of North America Hearing Loss Disease Treatment Market by Disease Type
7.4.2 Rest of North America Hearing Loss Disease Treatment Market by Product
7.4.3 Rest of North America Hearing Loss Disease Treatment Market by End-user
Chapter 8. Company Profiles
8.1 Novartis AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Astellas Pharma, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 WS Audiology A/S
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Otonomy, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.5 Sensorion
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Frequency Therapeutics, Inc
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.7 Acousia Therapeutics GmbH
8.7.1 Company Overview
8.8 Pipeline Therapeutics, Inc
8.8.1 Company Overview
8.9 Audina Hearing Instruments, Inc.
8.9.1 Company Overview
8.10. Audifon GmbH & CO. KG
8.10.1 Company Overview
TABLE 1 North America Hearing Loss Disease Treatment Market, 2018 - 2021, USD Million
TABLE 2 North America Hearing Loss Disease Treatment Market, 2022 - 2028, USD Million
TABLE 3 North America Hearing Loss Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 4 North America Hearing Loss Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 5 North America Sensorineural Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Sensorineural Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Conductive Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Conductive Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Mixed Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Mixed Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Hearing Loss Disease Treatment Market by Product, 2018 - 2021, USD Million
TABLE 12 North America Hearing Loss Disease Treatment Market by Product, 2022 - 2028, USD Million
TABLE 13 North America Devices Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Devices Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Drugs Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Drugs Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Hearing Loss Disease Treatment Market by End-user, 2018 - 2021, USD Million
TABLE 18 North America Hearing Loss Disease Treatment Market by End-user, 2022 - 2028, USD Million
TABLE 19 North America Otology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Otology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Ambulatory Clinics Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Ambulatory Clinics Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Hearing Loss Disease Treatment Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Hearing Loss Disease Treatment Market by Country, 2022 - 2028, USD Million
TABLE 27 US Hearing Loss Disease Treatment Market, 2018 - 2021, USD Million
TABLE 28 US Hearing Loss Disease Treatment Market, 2022 - 2028, USD Million
TABLE 29 US Hearing Loss Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 30 US Hearing Loss Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 31 US Hearing Loss Disease Treatment Market by Product, 2018 - 2021, USD Million
TABLE 32 US Hearing Loss Disease Treatment Market by Product, 2022 - 2028, USD Million
TABLE 33 US Hearing Loss Disease Treatment Market by End-user, 2018 - 2021, USD Million
TABLE 34 US Hearing Loss Disease Treatment Market by End-user, 2022 - 2028, USD Million
TABLE 35 Canada Hearing Loss Disease Treatment Market, 2018 - 2021, USD Million
TABLE 36 Canada Hearing Loss Disease Treatment Market, 2022 - 2028, USD Million
TABLE 37 Canada Hearing Loss Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 38 Canada Hearing Loss Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 39 Canada Hearing Loss Disease Treatment Market by Product, 2018 - 2021, USD Million
TABLE 40 Canada Hearing Loss Disease Treatment Market by Product, 2022 - 2028, USD Million
TABLE 41 Canada Hearing Loss Disease Treatment Market by End-user, 2018 - 2021, USD Million
TABLE 42 Canada Hearing Loss Disease Treatment Market by End-user, 2022 - 2028, USD Million
TABLE 43 Mexico Hearing Loss Disease Treatment Market, 2018 - 2021, USD Million
TABLE 44 Mexico Hearing Loss Disease Treatment Market, 2022 - 2028, USD Million
TABLE 45 Mexico Hearing Loss Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 46 Mexico Hearing Loss Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 47 Mexico Hearing Loss Disease Treatment Market by Product, 2018 - 2021, USD Million
TABLE 48 Mexico Hearing Loss Disease Treatment Market by Product, 2022 - 2028, USD Million
TABLE 49 Mexico Hearing Loss Disease Treatment Market by End-user, 2018 - 2021, USD Million
TABLE 50 Mexico Hearing Loss Disease Treatment Market by End-user, 2022 - 2028, USD Million
TABLE 51 Rest of North America Hearing Loss Disease Treatment Market, 2018 - 2021, USD Million
TABLE 52 Rest of North America Hearing Loss Disease Treatment Market, 2022 - 2028, USD Million
TABLE 53 Rest of North America Hearing Loss Disease Treatment Market by Disease Type, 2018 - 2021, USD Million
TABLE 54 Rest of North America Hearing Loss Disease Treatment Market by Disease Type, 2022 - 2028, USD Million
TABLE 55 Rest of North America Hearing Loss Disease Treatment Market by Product, 2018 - 2021, USD Million
TABLE 56 Rest of North America Hearing Loss Disease Treatment Market by Product, 2022 - 2028, USD Million
TABLE 57 Rest of North America Hearing Loss Disease Treatment Market by End-user, 2018 - 2021, USD Million
TABLE 58 Rest of North America Hearing Loss Disease Treatment Market by End-user, 2022 - 2028, USD Million
TABLE 59 Key Information – Novartis AG
TABLE 60 key information – Astellas Pharma, Inc.
TABLE 61 Key Information – WS Audiology A/S
TABLE 62 Key Information – Otonomy, Inc.
TABLE 63 Key Information – Sensorion
TABLE 64 Key Information – Frequency Therapeutics, INc.
TABLE 65 Key Information – Acousia Therapeutics GmbH
TABLE 66 Key Information – Pipeline Therapeutics, Inc
TABLE 67 Key Information – Audina Hearing Instruments, Inc.
TABLE 68 Key Information – Audifon GmbH & CO. KG
List of Figures
FIG 1 Methodology for the research